15 October 2018

Amedeo Smart

Independent Medical Education


Subscriber: th..@boehringer-ingelheim.com

HIV Infection

15 October 2018 | n=52

  1. McMillan J, Szlachetka A, Zhou T, Morsey B, et al.
    Pharmacokinetic testing of a first generation cabotegravir prodrug in rhesus macaques.
    AIDS 2018.

  2. Roul H, Mary-Krause M, Ghosn J, Delaugerre C, et al.
    CD4 cell count recovery after combined antiretroviral therapy in the modern cART era.
    AIDS 2018.

  3. Laut KG, Shepherd L, Gottfredsson M, Sedlacek D, et al.
    Variation in antiretroviral treatment (ART) coverage and virological suppression among three HIV key populations.
    AIDS 2018.

  4. Sudfeld CR, Buchanan A, Ulenga N, Spiegelman D, et al.
    Effectiveness of a multivitamin supplementation program among HIV-infected adults in Tanzania.
    AIDS 2018.

  5. Majonga ED, Rehman AM, Simms V, Mchugh G, et al.
    High prevalence of echocardiographic abnormalities in older HIV-infected children taking antiretroviral therapy.
    AIDS 2018.

  6. Stoner MCD, Nguyen N, Kilburn K, Gomez-Olive FX, et al.
    Age-disparate partnerships and incident HIV infection in adolescent girls and young women in rural South Africa: An HPTN 068 analysis.
    AIDS 2018.

  7. Galaviz KI, Schneider MF, Tien P, Mehta CC, et al.
    Predicting diabetes risk among HIV-positive and HIV-negative women: an assessment of the ADA and FINRISC diabetes risk scores.
    AIDS 2018.

  8. Erickson M, Shannon K, Sernick A, Pick N, et al.
    Women, incarceration and HIV: a systematic review of HIV treatment access, continuity of care and health outcomes across incarceration trajectories.
    AIDS 2018.

  9. Ford ES, Magaret AS, Spak CW, Selke S, et al.
    Increase in HSV shedding at initiation of antiretroviral therapy (ART) and decrease in shedding over time on ART in HIV and HSV-2 infected persons.
    AIDS 2018.

  10. Sabin CA, Harding R, Bagkeris E, Nkhoma K, et al.
    Pain in people living with HIV and its association with healthcare resource use, well-being and functional status.
    AIDS 2018.

  11. Maruthamuthu S, Raja R, Pandian K, Madasamy S, et al.
    Inhibitory NK cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians.
    AIDS 2018.

  12. Chowdhury FZ, Ouyang Z, Buzon M, Walker BD, et al.
    Metabolic pathway activation distinguish transcriptional signatures of CD8+ T cells from HIV-1 elite controllers.
    AIDS 2018.

  13. Vourli G, Pharris A, Cazein F, Costagliola D, et al.
    Are European HIV cohort data within EuroCoord representative of the diagnosed HIV population?
    AIDS 2018.

  14. Leal L, Guardo AC, Moron-Lopez S, Salgado M, et al.
    Phase I clinical trial of an intranodally administered mRNA based therapeutic vaccine against HIV-1 infection.
    AIDS 2018.

  15. Abrams EJ, Langwenya N, Gachuhi A, Zerbe A, et al.
    Impact of universal ART for pregnant and postpartum women on ART uptake and retention.
    AIDS 2018.

  16. Sundermann EE, Heaton RK, Pasipanodya E, Moore RC, et al.
    Sex differences in HIV-associated cognitive impairment: an observational cohort study.
    AIDS 2018.

  17. Nyamathi AM, Carpenter CL, Ekstrand ML, Yadav K, et al.
    Randomized controlled trial of a community-based intervention on HIV and nutritional outcomes at six months among women living with HIV/AIDS in Rural India.
    AIDS 2018.

  18. Lohmann S, White BX, Zuo Z, Chan MS, et al.
    HIV messaging on twitter: an analysis of current practice and data-driven recommendations.
    AIDS 2018.

  19. Debeaudrap P, Bodeau-Livinec F, Pasquier E, Germanaud D, et al.
    Neurodevelopmental outcomes in HIV-infected and uninfected African children aged 4 to 9 years from the pediacam cohort.
    AIDS 2018.

  20. Curtis AD, Walter K, Nabi R, Jensen K, et al.
    Oral co-administration of an intramuscular DNA/ Modified Vaccinia Ankara vaccine for simian immunodeficiency virus is associated with better control of infection in orally exposed infant macaques.
    AIDS Res Hum Retroviruses 2018.

  21. Payne H, Chain G, Adams S, Hunter P, et al.
    Naive B-cell output in HIV-infected and HIV-uninfected children.
    AIDS Res Hum Retroviruses 2018.

  22. Chen BA, Zhang J, Gundacker HM, Hendrix CW, et al.
    Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women.
    Clin Infect Dis 2018.

  23. Liu AY, Zhang J, Anderson PL, Wagner T, et al.
    Phase 1 Pharmacokinetic Trial of 2 Intravaginal Rings Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048.
    Clin Infect Dis 2018.

  24. Hoesley CJ, Chen BA, Anderson PL, Dezzutti CS, et al.
    Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings.
    Clin Infect Dis 2018.

  25. Massanella M, Karris MY, Perez-Santiago J, Yek C, et al.
    Analyses of Mitochondrial DNA and Immune Phenotyping Suggest Accelerated T-Cell Turnover in Treated HIV.
    J Acquir Immune Defic Syndr 2018;79:399-406.

  26. Mazhnaya A, Marcus R, Bojko MJ, Zelenev A, et al.
    Opioid Agonist Treatment and Improved Outcomes at Each Stage of the HIV Treatment Cascade in People Who Inject Drugs in Ukraine.
    J Acquir Immune Defic Syndr 2018;79:288-295.

  27. Lee WK, Milloy MJS, Nosova E, Walsh J, et al.
    Predictors of antiretroviral adherence self-efficacy among people living with HIV/AIDS in a Canadian setting.
    J Acquir Immune Defic Syndr 2018.

  28. Wang R, Shlipak MG, Ix JH, Brown TT, et al.
    The Association of Fibroblast Growth Factor-23 (FGF-23) with Incident Frailty in HIV-Infected and -Uninfected Individuals.
    J Acquir Immune Defic Syndr 2018.

  29. Robertson MM, Penrose K, Irvine MK, Robbins RS, et al.
    Impact of an HIV Care Coordination Program on Durable Viral Suppression.
    J Acquir Immune Defic Syndr 2018.

  30. Rodriguez-Gallego E, Tarancon-Diez L, Garcia F, Del Romero J, et al.
    Proteomic Profile Associated with Loss of Spontaneous HIV-1 Elite Control.
    J Infect Dis 2018.

  31. Suthar AB, Coggin W, Raizes E.
    Antimicrobial Resistance and Substandard and Falsified Medicines: The Case of HIV/AIDS.
    J Infect Dis 2018.

  32. Wallis CL, Godfrey C, Fitzgibbon JE, Mellors JW, et al.
    Reply to Suthar et al.
    J Infect Dis 2018.

  33. Xia Q, Coeytaux K, Braunstein SL, Torian LV, et al.
    Proposing a New Indicator for the National Human Immunodeficiency Virus/AIDS Strategy: Percentage of Newly Diagnosed Persons Achieving Viral Suppression Within 3 Months of Diagnosis.
    J Infect Dis 2018.

  34. Dombrowski JC, Baeten JM.
    It's Time to Make the Time to Viral Suppression After HIV Diagnosis a Metric of HIV Care Success.
    J Infect Dis 2018.

  35. Szaniawski MA, Spivak AM, Bosque A, Planelles V, et al.
    Sex influences SAMHD1 activity and susceptibility to HIV-1 in primary human macrophages.
    J Infect Dis 2018.

  36. Richards V.
    Should we consider marijuana use in relation to physical activity and cognitive impairment in persons with HIV infection?
    J Infect Dis 2018.

  37. Jaimes-Bernal C, Rallon N, Benito JM, Mohamed-Balghata MO, et al.
    Knock-out IFNL4 gene variant is associated with protection from sexually transmitted HIV-1 infection.
    J Infect Dis 2018.

  38. Soare AY, Durham ND, Gopal R, Tweel B, et al.
    P2X antagonists inhibit HIV-1 productive infection and inflammatory cytokines IL-10 and IL-1beta in a human tonsil explant model.
    J Virol 2018.

  39. Hoang TN, Harper JL, Pino MC, Wang H, et al.
    Bone marrow-derived CD4(+) T cells are depleted in SIV-infected macaques and contribute to the size of the replication competent reservoir on ART.
    J Virol 2018.

  40. Hargett AA, Wei Q, Knoppova B, Hall S, et al.
    Defining HIV-1 Envelope N-glycan Microdomains Through Site-specific Heterogeneity Profiles.
    J Virol 2018.

  41. Kinloch NN, Lee GQ, Carlson JM, Jin SW, et al.
    Genotypic and Mechanistic Characterization of Subtype-specific HIV Adaptation to Host Cellular Immunity.
    J Virol 2018.

  42. Webster P.
    PEPFAR at 15 years.
    Lancet 2018;392:200.

  43. Nakkazi E.
    Changes to dolutegravir policy in several African countries.
    Lancet 2018;392:199.

  44. Muftuoglu M, Olson A, Marin D, Ahmed S, et al.
    Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy.
    N Engl J Med 2018;379:1443-1451.

  45. Zash R, Makhema J, Shapiro RL.
    Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception.
    N Engl J Med 2018;379:979-981.

  46. Madrid L, Maculuve SA, Vilajeliu A, Saez E, et al.
    Maternal Carriage of Group B Streptococcus and Escherichia coli in a District Hospital in Mozambique.
    Pediatr Infect Dis J 2018;37:1145-1153.

  47. Cohen J.
    The Sunshine State's dark cloud.
    Science 2018;360:1176-1179.

  48. Cohen J.
    The loyal opposition.
    Science 2018;360:1175.

  49. Cohen J.
    The pill exchange.
    Science 2018;360:1174.

  50. Cohen J.
    Poster couple.
    Science 2018;360:1172.

  51. Cohen J.
    Status symbol.
    Science 2018;360:1171.

  52. Cohen J.
    Dark nights, bright stars.
    Science 2018;360:1170-1175.


Display articles in


Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:



Amedeo HIV Infection

Five-Week Literature

19 November 2018

12 November 2018

05 November 2018

29 October 2018

22 October 2018


15 October 2018

Multidisciplinary Journal Club

  1. Van Der Meeren O, Hatherill M, Nduba V, Wilkinson RJ, et al.
    Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis.
    N Engl J Med. 2018 Sep 25. doi: 10.1056/NEJMoa1803484.

  2. .
    Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.
    N Engl J Med. 2018 Sep 26. doi: 10.1056/NEJMoa1800474.

  3. Bath PM, Woodhouse LJ, Appleton JP, Beridze M, et al.
    Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.
    Lancet. 2017 Dec 20. pii: S0140-6736(17)32849.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016